Yasmin and Hepatic neoplasm - a phase IV clinical study of FDA data

Summary:

Hepatic neoplasm is reported as a side effect among people who take Yasmin (drospirenone; ethinyl estradiol), especially for people who are female, 20-29 old, have been taking the drug for 5 - 10 years also take Yaz, and have Premenstrual syndrome.

The phase IV clinical study analyzes which people have Hepatic neoplasm when taking Yasmin. It is created by eHealthMe based on reports of 47,831 people who have side effects when taking Yasmin from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Hepatic neoplasm?

Hepatic neoplasm (liver tumour) is found to be associated with 489 drugs and 519 conditions by eHealthMe. Check the latest studies of Hepatic neoplasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

47,831 people reported to have side effects when taking Yasmin.
Among them, 46 people (0.1%) have Hepatic neoplasm.

Among these 46 people:

How long have people been on Yasmin when they have Hepatic neoplasm? *

What is the gender of people who have Hepatic neoplasm when taking Yasmin? *

female: 97.83 %
male: 2.17 %

What is the age of people who have Hepatic neoplasm when taking Yasmin? *

What are other drugs people take besides Yasmin? *

Yaz: 20 people, 43.48%
Drospirenone And Ethinyl Estradiol: 8 people, 17.39%
Ibuprofen: 5 people, 10.87%
Amoxicillin: 5 people, 10.87%
Lisinopril: 4 people, 8.70%
Valtrex: 4 people, 8.70%
Prevacid: 4 people, 8.70%
Omnicef: 3 people, 6.52%
Gentamicin: 3 people, 6.52%
Cipro: 3 people, 6.52%

What are other side effects people have besides Hepatic neoplasm? *

Pain: 21 people, 45.65%
Gallbladder Disorder: 21 people, 45.65%
Cholecystitis Chronic (long lasting infection of gallbladder): 17 people, 36.96%
Gallstones (stone formation by bile component): 15 people, 32.61%
Stress And Anxiety: 13 people, 28.26%
Focal Nodular Hyperplasia (tumour of the liver): 12 people, 26.09%
Injury: 11 people, 23.91%
Emotional Distress: 9 people, 19.57%
Gallbladder Non-Functioning: 6 people, 13.04%
Abdominal Pain: 5 people, 10.87%

What are the existing conditions these people have? *

Premenstrual Syndrome: 7 people, 15.22%
Headache (pain in head): 5 people, 10.87%
Ovarian Cysts (fluid filled sacs of the ovary): 3 people, 6.52%
Menstruation Irregular: 3 people, 6.52%
Vaginal Bleeding: 2 people, 4.35%
High Blood Cholesterol: 2 people, 4.35%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 4.35%
Depression: 2 people, 4.35%
Dysmenorrhea (painful menstruation): 2 people, 4.35%
Herpes Zoster: 2 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and have Hepatic neoplasm?

- Check whether Hepatic neoplasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Yasmin:

Yasmin (48,855 reports)

Hepatic neoplasm treatments and more:

Hepatic neoplasm (4,831 reports)

How severe was Hepatic neoplasm and when was it recovered:

Hepatic neoplasm in Yasmin

Expand to all the drugs that have ingredients of drospirenone; ethinyl estradiol:

Hepatic neoplasm and drugs with ingredients of drospirenone; ethinyl estradiol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic neoplasm:

Hepatic neoplasm (489 drugs)

Browse all the conditions that are associated with Hepatic neoplasm:

Hepatic neoplasm (519 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol (the active ingredients of Yasmin) and Yasmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.